References
- Onor IO, Stirling DL, Williams SR, et al. Clinical effects of cigarette smoking: epidemiologic impact and review of pharmacotherapy options. Int J Environ Res Public Health. 2017 Sept 28;14(10).
- Colak Y, Afzal S, Nordestgaard BG, et al. Characteristics and prognosis of never-smokers and smokers with asthma in the copenhagen general population study. A prospective cohort study. Am J Respir Crit Care Med. 2015;192:172–9.
- Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675–679.
- World Health Organization E. 2017. [Cited 2017 Nov 11]. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/tobacco/data-and-statistics.
- The Public Health Agency of Sweden 2017. [Cited 2017 Nov 11]. Available from: https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/nationella-folkhalsoenkaten/levnadsvanor/tobaksvanor/
- Rodu B, Jansson JH, Eliasson M. The low prevalence of smoking in the Northern Sweden MONICA study, 2009. Scand J Public Health. 2013;41:808–811.
- Ramstrom L, Borland R, Wikmans T. Patterns of smoking and snus use in sweden: implications for public health. Int J Environ Res Public Health. 2016Nov 9;13(11).
- The Swedish National Register of COPD. Annual report 2016. [Cited 2017 Nov 11]. Available from: http://www.registercentrum.se/sites/default/files/dokument/luftvagsregistret_arsrapport_2016.pdf
- Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:Cd008286.
- The Swedish National Board of Health and Welfare. Vård vid astma och KOL 2015. [Cited 2017 Nov 11]. Available from: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19949/2015-11-3.pdf
- Lee CW, Kahende J. Factors associated with successful smoking cessation in the USA, 2000. Am J Public Health. 2007;97:1503–1509.
- Yang JJ, Song M, Yoon HS, et al. What are the major determinants in the success of smoking cessation: results from the health examinees study. PloS One. 2015;10:e0143303.
- Tottenborg SS, Thomsen RW, Johnsen SP, et al. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest. 2016;150:554–562.
- Lindberg A, Niska B, Stridsman C, et al. Low nicotine dependence and high self-efficacy can predict smoking cessation independent of the presence of chronic obstructive pulmonary disease: a three year follow up of a population-based study. Tob Induc Dis. 2015;13:27.
- van Eerd EA, Van Rossem CR, Spigt MG, et al. Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking. Respiration. 2015;90:211–219.
- Spruit MA, Polkey MI, Celli B, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13:291–297.
- Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104:550–556.
- Sundh J, Stallberg B, Lisspers K, et al. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. Copd. 2011;8:173–181.
- Sundh J, Janson C, Lisspers K, et al. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21:295–301.
- Sundh J, Janson C, Lisspers K, et al. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7:833–842.
- Lisspers K, Stallberg B, Janson C, et al. Sex-differences in quality of life and asthma control in Swedish asthma patients. J Asthma. 2013.
- Sundh J, Osterlund Efraimsson E, Janson C, et al. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22:393–399.
- Kampe M, Lisspers K, Stallberg B, et al. Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study. Eur Respir J. 2014 Sep 12;1.
- Sundh J, Stallberg B, Lisspers K, et al. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population. COPD. 2016;13(1):57-65.
- Sundh J, Montgomery S, Hasselgren M, et al. Change in health status in COPD: a seven-year follow-up cohort study. NPJ Prim Care Respir Med. 2016;26:16073.
- Sundh J, Lindgren H, Hasselgren M, et al. Pulmonary rehabilitation in COPD - available resources and utilization in Swedish primary and secondary care. Int J Chron Obstruct Pulmon Dis. 2017;12:1695–1704.
- Rijcken B, Schouten JP, Weiss ST, et al. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am Rev Respir Dis. 1987;136:62–68.
- Kohansal R, Martinez-Camblor P, Agusti A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180:3–10.
- Lundback B, Eriksson B, Lindberg A, et al. A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. Copd. 2009;6:263–271.
- Stratelis G, Molstad S, Jakobsson P, et al. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006;24:133–139.
- Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006;61:869–873.
- Stallberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23:38–45.
- Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3:CD001007.